Dr. Kolade is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4530 S Eastern Ave
Ste 1
Las Vegas, NV 89119Phone+1 702-629-7490
Summary
- Dr. Akindele Kolade is a psychiatrist based in Las Vegas ,NV. His specialties include addiction and child & adolescent psychiatry. Dr. Kolade received his education at Palacký University, University of Virginia Medical Center for his residency, and University of Miami/Jackson Health System where he completed his fellowship. In his career, he has held multiple roles such as Program Director at Montevista Hospital, Psychiatric Consultant at Sunrise Hospital and Medical Center, and currently serves as the owner of Cal Psychiatric Services.
Education & Training
- University of Miami/Jackson Health SystemFellowship, Child and Adolescent Psychiatry, 2003 - 2005
- University of Virginia Medical CenterResidency, Psychiatry, 2000 - 2003
- Palacký UniversityClass of 1988
- Palacky Univ- Fac MedClass of 1988
Certifications & Licensure
- CA State Medical License 2003 - 2027
- FL State Medical License 2023 - 2026
- NV State Medical License 2014 - 2025
- WA State Medical License 2022 - 2025
- American Board of Psychiatry and Neurology Psychiatry
- American Board of Psychiatry and Neurology Addiction Psychiatry
- American Board of Psychiatry and Neurology Child & Adolescent Psychiatry
Awards, Honors, & Recognition
- Doctor of the Day Doctor of the Day at the Florida Legislature 2006 session “Journal of the Senate”, Number 12-Regular session 2006. Legislative Medical Clinic., 2006
Research History
- Principal InvestigatorPI in 031-201-00301 A Phase 3b Multi-Center, Open-Label, Mirror-Image, Trial in Adult Subjects with Schizophrenia Treated Prospectively for 6- months with Abilify Mycite2019 - 2020
- PIPI in the Otsuka 331-10-234/236 A Phase III Multicenter, Randomized, Double-blind, Placebo- and Active-controlled Trial to Evaluate the Efficacy of Brexpiprazole Monotherapy for the Treatment in Adolescents (13-17 years old) With Schizophrenia Adolescent Schizophrenia2019 - 2020
- PIPI in the Allergan LVM-MD-11 A Phase III Double-blind, Placebo- and Active-Controlled Evaluation of the Safety and Efficacy of Levomilnacipran ER in Adolescent Patients with Major Depressive Disorder2019 - 2020
- Principal InvestigatorPI in Otsuka 316-13-217 A Multicenter, 180-day Pragmatic Clinical Trial to Measure the Difference in All-cause Hospitalizations for Patients who are Using Abilify MyCite versus Virtual Matched Controls in Adults with Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder2019 - 2020
- EducatorHealth Educator NIH funded research projects at the University of Wisconsin Milwaukee in two researches. “Stress Reduction, Primary Preventive intervention on heart diseases and the mortality and Morbidity in African Americans with Coronary Artery Diseases.” The first was testing the hypothesis that1999 - 2000
Professional Memberships
- Member
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: